注：本文系新闻报道，不构成投资建议，股市有风险，投资需谨慎。 亚星化学开盘涨停，公司今日披露非公开发行预案，拟通过发行股份及支付现金的方式购买天一控股等 24名股东持有的天一化学100%股权。同时，拟向包括潍坊市城投集团在内的不超过35名符合条件的特 定投资者发行股份募集配套资金。本次交易预计构成重大资产重组。 本次交易完成后，上市公司的主要产品将新增溴系列精细化工产品，包括四溴双酚A、溴化环氧树脂、 溴化聚苯乙烯、十溴二苯乙烷、氢溴酸等，以及标的公司新材料板块、钾盐板块、膜材料板块的各项产 品。本次交易有助于公司完善产品布局，增强盈利能力。（数据宝） （原标题：亚星化学开盘涨停，公司非公开发行预案披露） ...

停牌10个交易日后，11月17日晚间，亚星化学（600319）披露重组预案，公司拟通过发行股份及支付现金的方式购买天一控股等24名股东持有的天一化学 100%股权。同时，上市公司拟向包括潍坊市城投集团在内的不超过35名符合条件的特定投资者发行股份募集配套资金。 | 交易类型 | 交易对方名称 | | --- | --- | | 发行股份及支付现金购买资产 | 山东天一控股集团股份有限公司等 24 名山东天 | | | 一化学股份有限公司股东 | | 募集配套资金 | 包括潍坊市城市建设发展投资集团有限公司在内 | | | 的不超过 35 名符合条件的特定对象 | 公告显示，此次发行股份价格以定价基准日前120个交易日亚星化学A股股票交易均价的80%为依据，作价5.83元/股。 交易完成后，天一化学将成为上市公司全资子公司并纳入合并报表范围，公司控股股东仍为潍坊市城投集团，实际控制人仍为潍坊市国资委。 本次交易预计构成重大资产重组、构成关联交易、预计不构成重组上市。公司股票将于11月18日开市起复牌。 天一化学是国内溴系阻燃剂龙头供应商之一，是国家首批认定的高新技术企业、国家专精特新"小巨人"企业，业务涵盖溴系 ...

本次交易完成后，上市公司的主要产品将新增溴系列精细化工产品，包括四溴双酚A、溴化环氧树脂、 溴化聚苯乙烯、十溴二苯乙烷、氢溴酸等，以及标的公司新材料板块、钾盐板块、膜材料板块的各项产 品。 经向上海证券交易所申请，公司股票将于2025年11月18日开市起复牌。 格隆汇11月17日丨亚星化学(600319.SH)公布，公司拟通过发行股份及支付现金的方式购买山东天一控 股集团股份有限公司等24名股东持有的山东天一化学股份有限公司100%股权，并募集配套资金。 ...

本次交易完成后，上市公司的主要产品将新增溴系列精细化工产品，包括四溴双酚A、溴化环氧树脂、 溴化聚苯乙烯、十溴二苯乙烷、氢溴酸等，以及标的公司新材料板块、钾盐板块、膜材料板块的各项产 品。本次交易有助于公司完善产品布局，增强盈利能力，为公司的持续发展和行业地位的巩固奠定坚实 基础。 亚星化学（600319）(600319.SH)发布公告，公司拟通过发行股份及支付现金的方式购买天一控股等24 名股东持有的天一化学100%股权。同时，上市公司拟向包括潍坊市城投集团在内的不超过35名符合条 件的特定投资者发行股份募集配套资金。 经向上海证券交易所申请，公司股票将于2025年11月18日开市起复牌。 ...

智通财经APP讯，亚星化学(600319.SH)发布公告，公司拟通过发行股份及支付现金的方式购买天一控 股等24名股东持有的天一化学100%股权。同时，上市公司拟向包括潍坊市城投集团在内的不超过35名 符合条件的特定投资者发行股份募集配套资金。 本次交易完成后，上市公司的主要产品将新增溴系列精细化工产品，包括四溴双酚A、溴化环氧树脂、 溴化聚苯乙烯、十溴二苯乙烷、氢溴酸等，以及标的公司新材料板块、钾盐板块、膜材料板块的各项产 品。本次交易有助于公司完善产品布局，增强盈利能力，为公司的持续发展和行业地位的巩固奠定坚实 基础。 经向上海证券交易所申请，公司股票将于2025年11月18日开市起复牌。 ...

Core Viewpoint - Yaxing Chemical (600319) announced a major asset restructuring plan, intending to acquire 100% equity of Tianyi Chemical from 24 shareholders through a combination of share issuance and cash payment, with trading resuming on November 18 [1] Group 1: Transaction Details - The transaction is expected to constitute a significant asset restructuring and related party transaction, but it will not qualify as a restructuring listing [1] - Yaxing Chemical plans to raise supporting funds by issuing shares to no more than 35 qualified specific investors, including Weifang City Investment Group [1] Group 2: Business Impact - Tianyi Chemical operates in four main sectors: flame retardants, new materials, potassium salts, and membrane materials, and is a leading supplier in the brominated flame retardants market in China [1] - Post-transaction, Yaxing Chemical's product portfolio will expand to include brominated fine chemical products such as tetrabromobisphenol A, brominated epoxy resin, brominated polystyrene, decabromodiphenyl ether, and hydrobromic acid, along with products from Tianyi Chemical's new materials, potassium salts, and membrane materials sectors [1]

登录新浪财经APP 搜索【信披】查看更多考评等级 转自：经济导报 文|经济导报 刘勇 天一化学核心优势在于其溴系阻燃剂产品，其四溴双酚A、十溴二苯乙烷等产品在国内市场占有率超过 50%，部分水性功能单体在国际市场占有率高达70%以上，是细分领域的"隐形冠军"。 经济导报注意到，2022年天一化学曾开启上市辅导，但2023年终止了上市辅导。 近日，亚星化学(600319.SH)发布公告称，公司正在筹划以发行股份及支付现金方式购买山东天一化学 股份有限公司(下称"天一化学")控制权，或同步收购其他股东所持标的公司股份，同时拟发行股份募集 配套资金，本次交易预计构成重大资产重组及关联交易。 亚星化学在公告中表示，本次交易尚处于筹划阶段，有关事项存在不确定性。为了维护投资者利益，保 证公平信息披露，避免对公司股价造成重大影响，根据上海证券交易所的相关规定，经公司申请，公司 股票自2025年11月4日开市起停牌，预计停牌时间不超过10个交易日。 细分领域"隐形冠军" 天一化学成立于2002年11月，是一家以从事化学原料和化学制品制造业为主的企业，注册地山东省潍坊 市，注册资本8979.94万元，法定代表人李茂桉。 从股 ...

Core Viewpoint - The announcement of a major restructuring plan by Yaxing Chemical to acquire control of Tianyi Chemical has generated significant interest in the market, with questions about its potential to reverse Yaxing's continuous losses [1][5]. Group 1: Acquisition Details - Yaxing Chemical plans to acquire control of Tianyi Chemical through a combination of issuing shares and cash payments, which is expected to constitute a major asset restructuring and related party transaction [1][5]. - Tianyi Chemical, established in 2002, specializes in bromine series fine chemicals with an annual production capacity exceeding 60,000 tons and an annual output value of approximately 1 billion yuan [3]. - Tianyi Chemical has a dominant market position in its niche, holding over 50% market share in certain products domestically and up to 70% internationally for some water-based functional monomers [3]. Group 2: Financial Performance - Yaxing Chemical has faced declining performance, reporting a net loss of approximately 97.03 million yuan in 2024 and a negative net profit of 144 million yuan in the first three quarters of 2025 [3][7]. - The company has highlighted risks related to funding security in its annual and semi-annual reports, indicating financial constraints [3]. Group 3: Strategic Rationale - The acquisition is seen as a strategic move for Yaxing Chemical to enhance its market share and technological capabilities, potentially compensating for its weaknesses in new materials and high-end chemicals [7]. - Tianyi Chemical claims to have overcome several international monopolistic technologies, which could provide Yaxing with valuable technical advantages [5]. Group 4: Challenges and Considerations - The transaction involves complexities such as funding, equity dilution, and related party transactions, which require careful management and integration with existing operations [7][9]. - The timing of the acquisition coincides with Yaxing's major project launches, raising concerns about resource allocation and operational focus [9][11]. - Successful completion of the deal could enhance Yaxing's product lines and market share, but it also faces risks related to integration costs and short-term financial pressures [11].

Core Viewpoint - Yaxing Chemical is in the planning stage of acquiring Tianyi Chemical, a leading bromine industry company, through a combination of share issuance and cash payment, with the aim of gaining control over the target company [3][4] Group 1: Acquisition Details - Yaxing Chemical signed a preliminary investment cooperation agreement with Shandong Tianyi Holding Group on November 3, 2025, to acquire shares of Tianyi Chemical [3] - The agreement is still in the planning stage, and the specific transaction details will be determined in a formal agreement [3][4] - Tianyi Chemical, established in November 2002, specializes in the manufacturing of chemical raw materials and products, with a registered capital of 89.79 million yuan [3] Group 2: Tianyi Chemical's Business Overview - Tianyi Chemical has an annual production capacity of over 60,000 tons of various bromine series products, with an annual output value of 1 billion yuan [4][5] - The company holds over 80 patented technologies and has established seven major R&D platforms, achieving significant breakthroughs in the field [5] - Tianyi Chemical's brominated flame retardants dominate the domestic market with over 50% market share, and some products have a 70% share in international markets [5] Group 3: Yaxing Chemical's Financial Situation - Yaxing Chemical reported a revenue of 641 million yuan for the first three quarters of 2025, a year-on-year decrease of 2.53%, and a net profit attributable to shareholders of -144 million yuan [6] - The company is facing significant financial pressure while undergoing a critical transformation, with ongoing projects requiring substantial funding [6][7] - Key projects include a 45,000 tons/year high-end material project and two other projects, all expected to commence operations in the fourth quarter of 2025 [6][7]

Core Viewpoint - Yaxing Chemical is planning to acquire control of Shandong Tianyi Chemical Co., Ltd. through a combination of issuing shares and cash payments, which is expected to constitute a major asset restructuring and related party transaction [2][3] Group 1: Transaction Details - The transaction is currently in the planning stage, with the preliminary counterparty being the controlling shareholder of Tianyi Chemical, Shandong Tianyi Holding Group Co., Ltd. [3] - The transaction is not expected to change the actual controller of Yaxing Chemical and will not constitute a restructuring listing [3] - Yaxing Chemical's stock will be suspended from trading starting November 4, with an expected suspension period of no more than 10 trading days [3] Group 2: Tianyi Chemical Overview - Tianyi Chemical, established in November 2002, has a registered capital of 89.7994 million yuan and specializes in the research, development, and production of bromine series products [4] - The company has an annual production capacity of over 60,000 tons of various chemical products, including tetrabromobisphenol A and decabromodiphenyl ether, with an annual output value of 1 billion yuan [4] - Tianyi Chemical's bromine-based flame retardants hold over 50% market share domestically and up to 70% internationally for certain water-based functional monomers, positioning it as a "hidden champion" in its niche [4] Group 3: Strategic Implications - The acquisition is expected to leverage Tianyi Chemical's leading position and technical advantages in bromine chemicals, potentially enhancing Yaxing Chemical's business diversification and synergy effects, thereby improving long-term profitability and market confidence [4] - Investors are advised to pay attention to the valuation of the target assets, financing feasibility, and regulatory approval processes [4] Group 4: Ongoing Projects - Yaxing Chemical is advancing its 45,000 tons/year high-end new materials project, with equipment and installations nearing completion and expected to commence production in the fourth quarter [6] - The company is also progressing on its 500 tons/year hexachlorocyclotriphosphazene and 500 tons/year benzyl chloride ammonium industrialization projects, which are set to begin production in the fourth quarter as well [6]